ESC 365 - Which drugs and when to ablate: considerations in atrial fibrillation patients with and without heart failure.

ESC Premium Access

Which drugs and when to ablate: considerations in atrial fibrillation patients with and without heart failure.

Session: What's cooking? The most recent developments in atrial fibrillation management

Topic: Arrhythmias, General

Speaker: Professor J. Brachmann (Coburg, DE)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Johannes Brachmann

REGIOMED Kliniken, Coburg (Germany)

10 presentations

0 follower

3 more presentations in this session

Atrial fibrillation ablation: current experience, recent data and how it should be done.

Speaker: Professor A. Sarkozy (Brussels, BE)

NOAC: are they all the same - and as good as we think?

Speaker: Professor J. Oldgren (Uppsala, SE)

LAA closure: the next big thing?

Speaker: Doctor T. Feldman (Evanston, US)

Access the full session

What's cooking? The most recent developments in atrial fibrillation management

Speakers: Professor J. Brachmann, Professor A. Sarkozy, Professor J. Oldgren, Doctor T. Feldman

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by